LCAT and COVID-19: The LCAT protein is essential for cholesterolhomeostasis, and its inhibition can lead to cardiovascular disease. Disrupted cholesterol regulation may be linkedto a pro-atherogenic inflammatory response from SARS-CoV-2 infection, contributing to ischemic cardiovascular complicationsin COVID-19 patients.